Too early to say exactly, but as you know PYC remediates the disease genetically at the root level, precisely and elegantly, plays as close as possible around the germ line boundary
NEU is a general drug/peptide growth inhibitor, taken orally
whilst we don’t know the frequency and modality of PYC’s drug - it’s chalk and cheese - new vs old era of treatment - assuming it passes clinical trial safely (I.e. will supersede and make NEU treatment redundant if cost isn’t an issue)
Too early to say exactly, but as you know PYC remediates the...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
0.025(2.21%) |
Mkt cap ! $685.3M | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.18 | $1.11 | $117.3K | 103.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 855 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 8674 | 3 |
View Market Depth
| Last trade - 14.26pm 20/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |